{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:38:51Z","timestamp":1777959531622,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.diabres.2025.113059","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:53:20Z","timestamp":1766447600000},"page":"113059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metformin and all-cause mortality in older adults with type 2 diabetes mellitus and hypertension: NHANES 1999\u20132018 evidence for albumin as a mediator"],"prefix":"10.1016","volume":"231","author":[{"given":"Hongmei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diabres.2025.113059_b0005","first-page":"1241","article-title":"Associations of concurrent hypertension and type 2 T2DM with mortality outcomes: a prospective study of u.s. Adults","volume":"48","author":"Yuan","year":"2025","journal-title":"T2DM Care"},{"issue":"6","key":"10.1016\/j.diabres.2025.113059_b0010","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.118.11769","article-title":"Macrovasculature and microvasculature at the crossroads between type 2 T2DM mellitus and hypertension","volume":"73","author":"Climie","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.diabres.2025.113059_b0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12933-020-01138-w","article-title":"The additive effects of type 2 T2DM mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 t cardiac magnetic resonance study","volume":"19(1)","author":"Li","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.diabres.2025.113059_b0020","first-page":"554","article-title":"Associations of blood pressure with cardiovascular and mortality outcomes in over 2 million older persons with or without T2DM mellitus: a systematic review and meta-analysis of 45 cohort studies","volume":"17","author":"Seidu","year":"2023","journal-title":"Prim Care T2DM"},{"issue":"3","key":"10.1016\/j.diabres.2025.113059_b0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s13340-023-00628-y","article-title":"Causes of death in japanese people with type 2 T2DM and factors associated with all-cause mortality from a large registry in japan: the japan T2DM complication and its prevention prospective (jdcp) study-9","volume":"14","author":"Hayashino","year":"2023","journal-title":"Diabetol Int"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12933-025-02643-6","article-title":"The impact of metformin on kidney disease progression and mortality in diabetic patients using sglt2 inhibitors: a real-world cohort study","volume":"24","author":"Agur","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2025.113059_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40265-021-01665-0","article-title":"Association of metformin with the mortality and incidence of cardiovascular events in patients with pre-existing cardiovascular diseases","volume":"82","author":"Li","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12020-024-04012-x","article-title":"The impact of metformin on mortality in patients with type 2 T2DM mellitus: a prospective cohort study","volume":"87","author":"Zhang","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2025.113059_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1393513","article-title":"Associations of neutrophil-percentage-to-albumin ratio level with all-cause mortality and cardiovascular disease-cause mortality among patients with hypertension: evidence from nhanes 1999-2010","volume":"11","author":"Liu","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.diabres.2025.113059_b0050","article-title":"Association of prognostic nutritional index with the risk of all-cause mortality and cardiovascular mortality in patients with type 2 T2DM: nhanes 1999-2018","volume":"11","author":"Ning","year":"2023","journal-title":"BMJ Open T2DM Res Care"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0055","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41598-025-87253-8","article-title":"Correlation between neutrophil percentage-to-albumin ratio and all-cause and cerebrovascular mortality among hypertension patients","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.diabres.2025.113059_b0060","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nm.3787","article-title":"Metformin activates a duodenal ampk-dependent pathway to lower hepatic glucose production in rats","volume":"21","author":"Duca","year":"2015","journal-title":"Nat Med"},{"issue":"7899","key":"10.1016\/j.diabres.2025.113059_b0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal ampk pathway through pen2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41598-023-27974-w","article-title":"The negative association between serum albumin levels and coronary heart disease risk in adults over 45 years old: a cross-sectional survey","volume":"13","author":"Hou","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12933-024-02191-5","article-title":"The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2025.113059_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103327","article-title":"Association between the oxidative balance score and all-cause and cardiovascular mortality in patients with T2DM and preT2DM","volume":"76","author":"Xu","year":"2024","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in cvd patients with T2DM or pre-T2DM: evidence from nhanes 2001-2018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12916-024-03484-y","article-title":"Metformin use correlated with lower risk of cardiometabolic diseases and related mortality among us cancer survivors: evidence from a nationally representative cohort study","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11606-019-05398-5","article-title":"Trends in self-reported preT2DM and metformin use in the usa: nhanes 2005-2014","volume":"35","author":"Liu","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.diabres.2025.113059_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on T2DM control: a systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.diabres.2025.113059_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204859","article-title":"Effects of metformin use on total mortality in patients with type 2 T2DM and chronic obstructive pulmonary disease: a matched-subject design","volume":"13","author":"Yen","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCHEARTFAILURE.110.952556","article-title":"Metformin use and mortality in ambulatory patients with T2DM and heart failure","volume":"4","author":"Aguilar","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.diabres.2025.113059_b0120","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/brain\/awad366","article-title":"Metformin in elderly type 2 T2DM mellitus: dose-dependent dementia risk reduction","volume":"147","author":"Sun","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.diabres.2025.113059_b0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14423\/SMJ.0000000000001363","article-title":"Propensity score matching to determine the impact of metformin on all-cause mortality in older veterans with T2DM mellitus","volume":"115","author":"Ferri-Guerra","year":"2022","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.diabres.2025.113059_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020319","article-title":"Metformin inhibits ros production by human m2 macrophages via the activation of ampk","volume":"10","author":"Nassif","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.diabres.2025.113059_b0135","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin improves mitochondrial respiratory activity through activation of ampk","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.diabres.2025.113059_b0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.12717\/DR.2019.23.2.119","article-title":"Synergistic enhancement of paclitaxel-induced inhibition of cell growth by metformin in melanoma cells","volume":"23","author":"Ko","year":"2019","journal-title":"Dev Reprod"},{"issue":"2","key":"10.1016\/j.diabres.2025.113059_b0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/ph14020152","article-title":"Therapeutic applications of type 2 T2DM mellitus drug metformin in patients with osteoarthritis","volume":"14","author":"Song","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.diabres.2025.113059_b0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.kint.2022.01.037","article-title":"Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats","volume":"101","author":"Corremans","year":"2022","journal-title":"Kidney Int"},{"issue":"21","key":"10.1016\/j.diabres.2025.113059_b0155","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108028","article-title":"Cars senses cysteine deprivation to activate ampk for cell survival","volume":"40","author":"Yuan","year":"2021","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08585-4","article-title":"Post-translational regulation of lipogenesis via ampk-dependent phosphorylation of insulin-induced gene","volume":"10","author":"Han","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabres.2025.113059_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.751938","article-title":"Therapeutic targeting of nonalcoholic fatty liver disease by downregulating srebp-1c expression via ampk-klf10 axis","volume":"8","author":"Chen","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.diabres.2025.113059_b0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2411-6","article-title":"Tnf-receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in nafld mice","volume":"11","author":"Wandrer","year":"2020","journal-title":"Cell Death Dis"},{"issue":"22","key":"10.1016\/j.diabres.2025.113059_b0175","doi-asserted-by":"crossref","first-page":"12582","DOI":"10.1021\/acs.jafc.4c02606","article-title":"Tea polysaccharide ameliorates high-fat diet-induced renal tubular ectopic lipid deposition via regulating the dynamic balance of lipogenesis and lipolysis","volume":"72","author":"Kuang","year":"2024","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0180","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/jcmm.14785","article-title":"\u0391\u2010mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the ampk\/srebp1 cascades","volume":"24","author":"Shi","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.diabres.2025.113059_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s44200-023-00034-4","article-title":"Patients with ckd secondary to glomerular disorders have lower arterial stiffness, as compared to hypertensive and diabetic ckd","volume":"29","author":"Lencovsky","year":"2023","journal-title":"Artery Res"},{"key":"10.1016\/j.diabres.2025.113059_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.896847","article-title":"A nutrition-related factor-based risk stratification for exploring the clinical benefits in the treatment of patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy: a retrospective cohort study","volume":"9","author":"Yu","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.diabres.2025.113059_b0195","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.8203","article-title":"Medical comorbidities and association with mortality risk in alzheimer\u2019s disease: population-based study of 132,405 geriatric inpatients","author":"Yen","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.diabres.2025.113059_b0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41440-019-0212-z","article-title":"Metformin prevents vascular damage in hypertension through the ampk\/er stress pathway","volume":"42","author":"Chen","year":"2019","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.diabres.2025.113059_b0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13054-019-2346-4","article-title":"Association of preadmission metformin use and mortality in patients with sepsis and T2DM mellitus: a systematic review and meta-analysis of cohort studies","volume":"23","author":"Liang","year":"2019","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.diabres.2025.113059_b0210","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.hlc.2021.06.518","article-title":"Comparison of different cardiovascular risk score and pulse wave velocity-based methods for vascular age calculation","volume":"30","author":"Gy\u00f6ngy\u00f6si","year":"2021","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.diabres.2025.113059_b0215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jdiacomp.2017.01.013","article-title":"Differential effects of metformin on age related comorbidities in older men with type 2 T2DM","volume":"31","author":"Wang","year":"2017","journal-title":"J T2DM Complications"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:19:09Z","timestamp":1769696349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725010745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0168822725010745"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113059","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin and all-cause mortality in older adults with type 2 diabetes mellitus and hypertension: NHANES 1999\u20132018 evidence for albumin as a mediator","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113059"}}